AbbVie’s SKYRIZI® Gains FDA Approval for Moderate to Severe Ulcerative Colitis and Crohn's Disease Following Successful Phase 3 Trials

AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for adults with moderately to severely ac...

June 20, 2024 | Thursday | News
Bio-Rad Laboratories Introduces Advanced Single-Cell RNA-Seq Kit and Analysis Software

Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics products, announced the launch of the ddSEQTM Single-Cell 3' RNA-...

June 20, 2024 | Thursday | News
Skytree and Purolite Forge Strategic Partnership to Advance CO2 Capture Technology

Skytree, a pioneering climate tech company specializing in carbon utilization and removal solutions, today announced it has signed strategic multi-year...

June 19, 2024 | Wednesday | News
Thermo Fisher Scientific Launches State-of-the-Art Clinical Research Lab in Wisconsin

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, unveiled a new clinical research laboratory build...

June 18, 2024 | Tuesday | News
RevOpsis and Kemwell Partner to Accelerate Development of RO-104 for nAMD

Partnership to accelerate development of lead product candidate, RO-104; a first-in-class tri-specific biologic for treating neovascular age-relat...

June 18, 2024 | Tuesday | News
Roche's Digital Pathology System Receives FDA Clearance for Clinical Diagnosis

The solution, which includes the VENTANA DP 200 slide scanner, Roche's digital pathology workflow software and a display, is now cl...

June 18, 2024 | Tuesday | News
Thermo Fisher Scientific's PPD Clinical Research Business Earns 13th Consecutive CRO Leadership Award

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, is embracing the theme of the 60th annual Drug ...

June 17, 2024 | Monday | News
LIXTE Biotechnology Announces Clinical Trial Collaboration with Roche and NKI for MSI Low Metastatic Colon Cancer

LIXTE Biotechnology Holdings, Inc.  a clinical stage pharmaceutical company, today announced a collaboration with Roche and the Netherlands Cancer I...

June 17, 2024 | Monday | News
Moderna's Next-Gen COVID-19 Vaccine mRNA-1283 Excels in Phase 3 Trial

Moderna, announced that its Phase 3 trial of mRNA-1283, an investigational next-generation COVID-19 vaccine, has met its primary efficacy endpoint, demon...

June 17, 2024 | Monday | News
Biosplice Therapeutics and Novo Nordisk Partner to Develop Innovative Diabetes Treatments Targeting DYRK Inhibition

  Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on smal...

June 13, 2024 | Thursday | News
ValGenesis and Célere Partner to Deliver Advanced Digital Validation Solutions

ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and Célere, a life sciences-focused consultancy i...

June 12, 2024 | Wednesday | News
Global Cancer Cases Set to Surge to 32 Million Annually by 2050, with Dramatic Increases in Low-Income Countries

Cancer incidence is expected to rise significantly through 2050, particularly in lower-income countries, to 32 million new cases annually – a pot...

June 11, 2024 | Tuesday | Reports
Abu Dhabi Signs Landmark MoU with ADIO, Etihad Airways, and AD Ports Group to Become Global Pharma and Life Sciences Hub

BIO International Convention 2024, The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, and Abu Dhabi...

June 10, 2024 | Monday | News
Asensus Surgical to be Acquired by KARL STORZ in $300 Million Deal

Asensus Surgical, , a global leader of innovative digital solutions for the operating room, today announced that it has entered into a definitive merger ...

June 10, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close